Early Phase 1 Parkinson's Disease Trial, Not Yet Recruiting NCT07214974 Sponsor: Noah Tech, Corp. Condition: Parkinson's Disease
Back to Parkinsons Disease

Early Phase 1 Parkinson's Disease Trial, Not Yet Recruiting

NCT07214974
Not Yet Recruiting Early Phase 1

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults who are 55 years of age or older
  • People who live in urban or suburban communities in the United States
  • People who are able to give their informed consent to take part
  • People who are willing to attend follow-up assessments over a 3-year period
  • People who are able to complete cognitive (thinking and memory) screening tests
  • People who have a way to get to appointments held in the community
  • People who have never received a formal diagnosis of dementia

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are under 55 years of age
  • People who currently have a diagnosis of moderate to severe dementia
  • People with severe mental health conditions that would affect the reliability of assessment results
  • People with an active substance abuse disorder
  • People with severe vision or hearing problems that cannot be corrected and would prevent them from completing the assessments
  • People with a terminal illness where life expectancy is expected to be less than 3 years
  • People who are currently taking part in another research study focused on cognitive (thinking and memory) interventions
  • People who are unable to attend follow-up appointments because they plan to move to a different location
  • People with significant neurological conditions — such as stroke, traumatic brain injury, or Parkinson's disease — that could affect cognitive assessment results
  • People who live in institutional care settings such as nursing homes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

If this is close to home

This page includes language about advanced illness, prognosis, or palliative care, because that is how the trial's eligibility criteria are written. Seeing it set out plainly can land hard, whether it is about you or about someone you are caring for. You do not have to be at a crisis point to talk to someone.

  • Griefline — grief and loss counselling, 9am to 6pm weekdays and midday to 6pm weekends (AEST/AEDT): 1300 845 745
  • Carer Gateway — practical and emotional support if you are caring for someone, 8am to 5pm weekdays: 1800 422 737
  • Canteen — for 12 to 25 year olds affected by cancer, their own or a family member's: 1800 945 215
  • Palliative Care Australia — directory of palliative care services near you: palliativecare.org.au
  • Lifeline — 24/7, for any kind of distress, at any hour the services above are closed: 13 11 14

Palliative care is not the same as giving up on treatment, and it is not only for the last weeks of life. It is symptom and comfort care that can run alongside active treatment, including a clinical trial.

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of support and crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention.

Voxsanity is not a counselling or medical service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Contact this trial

Phone: 6504895808

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Early Phase 1
Sponsor
Noah Tech, Corp.
Registry
ClinicalTrials.gov
Start date
1 September 2026
Est. completion
30 September 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Cognitive Function as Measured by MoCA Score; Rate of Progression to Dementia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov